gut.bmj1d
Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis
Correspondence to Dr Silvia Sookoian, and Dr Carlos J Pirola, Instituto de Investigaciones Medicas, IDIM-CONICET, Combatientes de Malvinas 3150, CABA-1427, Argentina; ...
gut.bmj1d
COVID-19 and liver disease
Knowledge on SARS-CoV-2 infection and its resultant COVID-19 in liver diseases has rapidly increased during the pandemic. Hereby, we review COVID-19 liver manifestations and pathophysiological aspects ...
gut.bmj2d
An evidence-based appraisal of reflux disease management — the Genval Workshop Report
aDepartment of Gastrointestinal Medicine, Royal Adelaide Hospital, Adelaide, Australia, bSödra Hõlsocentralen, Hudiksvall, Sweden, cUniversity of Michigan Health ...
gut.bmj3d
Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study
Correspondence to Julien Kirchgesner, Service de Gastroentérologie et Nutrition, Hôpital Saint-Antoine, Assistance Publique - Hôpitaux de Paris, 184 rue du faubourg Saint-Antoine, Paris 75012, France; ...
gut.bmj3d
Online First
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, ...
gut.bmj3d
Global incidence of oesophageal cancer by histological subtype in 2012
Correspondence to Dr Melina Arnold, Section of Cancer Surveillance, International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon 69008, France; arnoldm{at}fellows.iarc.fr Objective The ...
gut.bmj4d
Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial
Background: Three large randomised trials have shown that screening for colorectal cancer using faecal occult blood (FOB) tests can reduce the mortality from this disease. Two national pilot studies ...
gut.bmj4d
Liquid biopsy in the clinical management of hepatocellular carcinoma
Correspondence to Dr Johann von Felden, Department of Internal Medicine, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; j.von-felden{at}uke.de; Dr Augusto Villanueva, Liver Cancer Program, ...
gut.bmj4d
Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing
Objective Tumour heterogeneity represents a major obstacle to accurate diagnosis and treatment in gastric adenocarcinoma (GA). Here, we report a systematic transcriptional atlas to delineate molecular ...
gut.bmj4d
Epidemiology of gastro-oesophageal reflux disease: a systematic review
Correspondence to: Professor J Dent Department of Gastroenterology, Hepatology, and General Medicine, Level 7, North Wing, North Terrace, Royal Adelaide Hospital, Adelaide, South Australia 5000, ...
gut.bmj5d
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome
Dr R Spiller, Division of Gastroenterology, C Floor, South Block, University Hospital, Nottingham NG7 2UH, UK. Email:Robin.Spiller{at}nottingham.ac.uk These guidelines were compiled by a ...
gut.bmj5d
Optimum bile acid treatment for rapid gall stone dissolution.
To determine the optimum bile acid regimen for rapid gall stone dissolution, 48 gall stone patients were divided into four groups of 12 according to stone diameter and were randomly allocated to ...